Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/157
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Giorgi, Riccardo
dc.date.accessioned2019-01-04T11:12:30Z
dc.date.available2019-01-04T11:12:30Z
dc.date.issued2018-12-17
dc.identifier.citationRiccardo de Giorgi. Vortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNER. BJPsych Advances Vol 25. 1 2019 p3-6.en
dc.identifier.issn2056-4686
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/157
dc.descriptionThe article attached to this record is the Author(s) pre-/post- print version only. NOTE: this is not the version published in BJPsych Advances. Minor changes may have been made for publication. Eligible users can access the full text via NHS OpenAthens (login required)
dc.description.abstractThe pharmacological treatment of depression is often hampered by side-effects and unsatisfactory response to treatment. Vortioxetine is one of the newest antidepressants on the market, purportedly with a different mechanism of action compared with other antidepressants. This month's Cochrane Corner review examines the evidence available for the use of vortioxetine as a first-line treatment for depression in adults. This commentary puts the Cochrane review's findings into their clinical context and revises them in view of earlier and later studiesen
dc.description.urihttps://doi.org/10.1192/bja.2018.62
dc.language.isoenen
dc.subjectDepressive Disordersen
dc.subjectAntidepressant Drugsen
dc.titleVortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNERen
dc.typePrePrinten
Appears in Collections:Depressive Disorders
BJPsych Advances publications

Files in This Item:
File Description SizeFormat 
BJPsych Adv Round the corner - Vortioxetine for depression in adults.pdfPrePrint225.17 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.